138 related articles for article (PubMed ID: 11676297)
1. Evaluation of 99mTc-MAMA-chrysamine G as an in vivo probe for amyloidosis.
Dezutter NA; Landman WJ; Jager PL; de Groot TJ; Dupont PJ; Tooten PC; Zekarias B; Gruys E; Verbruggen AM
Amyloid; 2001 Sep; 8(3):202-14. PubMed ID: 11676297
[TBL] [Abstract][Full Text] [Related]
2. In vitro affinity of 99Tcm-labelled N2S2 conjugates of chrysamine G for amyloid deposits of systemic amyloidosis.
Dezutter NA; Sciot RM; de Groot TJ; Bormans GM; Verbruggen AM
Nucl Med Commun; 2001 May; 22(5):553-8. PubMed ID: 11388578
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer's disease.
Dezutter NA; Dom RJ; de Groot TJ; Bormans GM; Verbruggen AM
Eur J Nucl Med; 1999 Nov; 26(11):1392-9. PubMed ID: 10552079
[TBL] [Abstract][Full Text] [Related]
4. Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component.
Nelson SR; Hawkins PN; Richardson S; Lavender JP; Sethi D; Gower PE; Pugh CW; Winearls CG; Oliver DO; Pepys MB
Lancet; 1991 Aug; 338(8763):335-9. PubMed ID: 1677697
[TBL] [Abstract][Full Text] [Related]
5. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.
Hawkins PN; Myers MJ; Epenetos AA; Caspi D; Pepys MB
J Exp Med; 1988 Mar; 167(3):903-13. PubMed ID: 3351437
[TBL] [Abstract][Full Text] [Related]
6. 'Localized amyloidosis': 123I-labelled SAP component scintigraphy and labial salivary gland biopsy.
Maulin L; Hachulla E; Deveaux M; Janin A; Wechsler B; Godeau P; Rousset H; Barrier JH; Hatron PY; Devulder B; Huglo D; Marchandise X
QJM; 1997 Jan; 90(1):45-50. PubMed ID: 9093588
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.
Hawkins PN; Lavender JP; Pepys MB
N Engl J Med; 1990 Aug; 323(8):508-13. PubMed ID: 2377176
[TBL] [Abstract][Full Text] [Related]
8. Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis.
Hachulla E; Maulin L; Deveaux M; Facon T; Blétry O; Vanhille P; Wechsler B; Godeau P; Levesque H; Hatron PY; Huglo D; Devulder B; Marchandise X
Am J Med; 1996 Jul; 101(1):77-87. PubMed ID: 8686719
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.
Hazenberg BP; van Rijswijk MH; Piers DA; Lub-de Hooge MN; Vellenga E; Haagsma EB; Hawkins PN; Jager PL
Am J Med; 2006 Apr; 119(4):355.e15-24. PubMed ID: 16564782
[TBL] [Abstract][Full Text] [Related]
10. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis.
Saïle R; Deveaux M; Hachulla E; Descamps J; Duquesnoy B; Marchandise X
Eur J Nucl Med; 1993 Feb; 20(2):130-7. PubMed ID: 8440269
[TBL] [Abstract][Full Text] [Related]
11. [Scintigraphy of iodine 123 labelled serum amyloid P component in beta 2-microglobulin amyloidosis of hemodialysis].
Flipo RM; Deveaux M; Duneton O; Foissac-Gegoux P; Dumont A; Duquesnoy B; Marchandise X
Nephrologie; 1995; 16(6):419-25. PubMed ID: 8524449
[TBL] [Abstract][Full Text] [Related]
12. Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis.
Hawkins PN; Aprile C; Capri G; Viganò L; Munzone E; Gianni L; Pepys MB; Merlini G
Eur J Nucl Med; 1998 Jul; 25(7):701-8. PubMed ID: 9662591
[TBL] [Abstract][Full Text] [Related]
13. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology of unilateral amyloid arthropathy in broiler breeders associated with Enterococcus faecalis.
Steentjes A; Veldman KT; Mevius DJ; Landman WJ
Avian Pathol; 2002 Feb; 31(1):31-9. PubMed ID: 12425790
[TBL] [Abstract][Full Text] [Related]
15. In search of the ideal radiotracer for soft-tissue amyloid scanning.
Lee VW; Shah NP
Amyloid; 2001 Sep; 8(3):220-1. PubMed ID: 11676299
[No Abstract] [Full Text] [Related]
16. Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component.
Hawkins PN; Myers MJ; Lavender JP; Pepys MB
Lancet; 1988 Jun; 1(8600):1413-8. PubMed ID: 2898580
[TBL] [Abstract][Full Text] [Related]
17. [Localized or systemic amyloidosis? Value and limitations of Iodine-123 labelled amyloid P component scintigraphy, role of biopsy of minor salivary glands].
Hachulla E; Wechsler B; Deveaux M; Godeau P; Hatron PY; Devulder B; Janin A; Marchandise X
Rev Med Interne; 1994 Mar; 15(3):182-5. PubMed ID: 8059132
[TBL] [Abstract][Full Text] [Related]
18. The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.
Lovat LB; Persey MR; Madhoo S; Pepys MB; Hawkins PN
Gut; 1998 May; 42(5):727-34. PubMed ID: 9659172
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis.
Hazenberg BP; van Rijswijk MH; Lub-de Hooge MN; Vellenga E; Haagsma EB; Posthumus MD; Jager PL
J Nucl Med; 2007 Jun; 48(6):865-72. PubMed ID: 17504868
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and monitoring of amyloidosis.
Hawkins PN
Baillieres Clin Rheumatol; 1994 Aug; 8(3):635-59. PubMed ID: 7954867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
